首页> 外文期刊>Current opinion in critical care >Selection of endpoints for clinical trials of acute renal failure in critically ill patients.
【24h】

Selection of endpoints for clinical trials of acute renal failure in critically ill patients.

机译:在危重病人中进行急性肾衰竭临床试验的终点选择。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The selection of appropriate outcome measures is essential to the design of clinical trials of the prevention or treatment of acute renal failure in critically ill patients. In this paper, we present the consensus opinion from the second Acute Dialysis Quality Initiative Conference held in Vicenza, Italy, in May 2002, regarding the issues that should guide the selection of endpoints in clinical intervention trials of acute renal failure. Important criteria for the selection of these outcome measures include their clinical importance, responsiveness to experimental intervention, precision of definition, accuracy of measurement, and completeness of ascertainment. Although the most appropriate endpoints for individual studies are dependent on specific hypotheses and study designs, the primary endpoint in prevention trials should be based on an assessment of renal function, whereas mortality or renal functional assessment may serve as the primary endpoint in studies of established acute renal failure.
机译:选择适当的结局指标对于预防或治疗重症患者急性肾衰竭的临床试验设计至关重要。在本文中,我们提出了2002年5月在意大利维琴察举行的第二次“急性透析质量倡议”会议上的共识性意见,这些问题应指导急性肾衰竭临床干预试验的终点选择。选择这些结局指标的重要标准包括其临床重要性,对实验干预的反应性,定义的准确性,测量的准确性以及确定性的完整性。尽管个别研究最合适的终点取决于特定的假设和研究设计,但预防性试验的主要终点应基于对肾功能的评估,而死亡率或肾功能评估可以作为已建立的急性研究的主要终点肾衰竭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号